From: Incremental prognostic value of global longitudinal strain in patients with type 2 diabetes mellitus
Variable | Value (n = 247) | B | HR (95 % CI) | P |
---|---|---|---|---|
IVSd (cm) | 1.13 ± 0.19 | |||
Univariate analysis | 2.01 | 7.43 (0.66–83.7) | 0.10 | |
Adjusted clinical dataa | 1.43 | 4.17 (0.31–56.8) | 0.28 | |
Adjusted clinical data + HbA1c | 1.87 | 6.50 (0.47–89.5) | 0.16 | |
RWT, ratio | 0.50 ± 0.09 | |||
Univariate analysis | −0.47 | 0.63 (0.002–171.5) | 0.87 | |
Adjusted clinical dataa | −1.25 | 0.29 (0.001–89.3) | 0.67 | |
Adjusted clinical data + HbA1c | 0.87 | 2.39 (0.01–783.1) | 0.77 | |
LVMI (g/m2) | 100.7 ± 24.7 | |||
Univariate analysis | 0.02 | 1.02 (1.00–1.03) | 0.07 | |
Adjusted clinical dataa | 0.01 | 1.01 (0.99–1.04) | 0.29 | |
Adjusted clinical data + HbA1c | 0.01 | 1.01 (0.99–1.04) | 0.27 | |
LVEF (%) | 63.2 ± 4.5 | |||
Univariate analysis | −0.08 | 0.92 (0.83–1.02) | 0.13 | |
Adjusted clinical dataa | −0.07 | 0.94 (0.85–1.04) | 0.19 | |
Adjusted clinical data + HbA1c | −0.08 | 0.93 (0.84–1.02) | 0.11 | |
E/A ratio | 0.94 ± 0.31 | |||
Univariate analysis | −2.51 | 0.08 (0.01–0.98) | 0.05 | |
Adjusted clinical dataa | −1.05 | 0.35 (0.02–6.09) | 0.47 | |
Adjusted clinical data + HbA1c | −1.62 | 0.20 (0.01–4.04) | 0.29 | |
E/E′ ratio | 10.4 ± 4.5 | |||
Univariate analysis | 0.15 | 1.16 (1.10–1.22) | <0.01 | |
Adjusted clinical dataa | 0.14 | 1.16 (1.09–1.23) | <0.01 | |
Adjusted clinical data + HbA1c | 0.14 | 1.15 (1.08–1.22) | <0.01 | |
GLS (%) | −18.1 ± 2.4 | |||
Univariate analysis | 0.27 | 1.31 (1.10–1.56) | <0.01 | |
Adjusted clinical dataa | 0.29 | 1.35 (1.10–1.65) | <0.01 | |
Adjusted clinical data + HbA1c | 0.33 | 1.39 (1.14–1.70) | <0.01 |